‹ All Posts
Chahat Aggrawal

2nd Mar 2025 · SEBI-Registered Analyst

Glenmark Recalls 1.5 Million Bottles of ADHD Drug in US

💊

GLENMARK
is recalling 1.5 million bottles of Atomoxetine Capsules in the US due to N-Nitroso Atomoxetine impurity exceeding FDA limits. The recall, covering strengths from 10 mg to 100 mg, was initiated on January 29, 2025.

#FundamentalViews#StockInNews
185 likes·34 comments